This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

CALVIN M. KUNIN, M.D.; MAXWELL FINLAND, M.D.

AMA Arch Intern Med. 1959;104(6):1030-1050.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

When a drug which is normally excreted in large part by the kidneys is administered repeatedly to a patient with renal failure, it will tend to be retained and may accumulate in the body. The retention of large amounts of certain drugs can produce undesirable effects so that it may be prudent to reduce the size or frequency of the doses. On the other hand, undue caution may deny the patient adequate therapy and be as disadvantageous as overzealous treatment.

Prolonged administration of large doses of some of the antibiotics currently in clinical use is not entirely innocuous. Liver and renal damage, negative nitrogen balance, and increased excretion of riboflavin as well as certain vitamins and amino acids into the urine may occur in patients treated with any of the tetracyclines.^1-9 Renal damage has been noted with the use of bacitracin,^10-14 the polymyxins,^15-22 neomycin,^15,23 and kanamycin.²⁴ Damage to vestibular or . . . [Full Text PDF of this Article]

Author Affiliations
Charlottesville, Va.; Boston

From the Thorndike Memorial Laboratory, Second and Fourth (Harvard) Medical Services, Boston City Hospital, and the Department of Medicine, Harvard Medical School, Boston.

Footnotes
Submitted for publication Aug. 7, 1959.

Some of the authors' studies quoted in this review were aided, in part, by a grant (E-23) from the National Institutes of Health.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?